Studies from breast cancer cells showed that SOX4 is a downstream of Transforming growth factor beta (TGFβ) signaling and that SOX4 expression was required for TGFβ-mediated induction of a subset of SMAD3/SOX4-co-bound genes (35). Here, SMAD3 is linked to breast carcinoma.